Clinical Trials on Clinical Manifestation of COVID-19 in South Africa
Total 372 results
-
NovavaxActive, not recruiting
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, United Kingdom
-
Regeneron PharmaceuticalsTerminatedCOVID-19United States, Mexico, Romania
-
AstraZenecaIqvia Pty LtdCompletedPhase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOVID-19 | SARS-CoV-2United States, Chile, Peru
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Korea, Republic of
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Blade TherapeuticsClinipace WorldwideCompletedCovid19 | Sars-CoV-2United States, Brazil
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
IpsenCompletedMuscle Spasticity | Cerebrovascular AccidentAustralia
-
PfizerCompleted
-
GlaxoSmithKlineRecruitingRespiratory Syncytial Virus InfectionsUnited States, Belgium, Netherlands, Spain
-
Alexion PharmaceuticalsTerminatedPneumonia, Viral | Acute Respiratory Distress Syndrome | Acute Lung Injury | COVID-19 Severe PneumoniaUnited States, Spain, United Kingdom, France, Japan
-
Arcturus Therapeutics, Inc.TerminatedCovid19 | Corona Virus Infection | SARS-CoV InfectionUnited States, Singapore
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
Regeneron PharmaceuticalsCompleted
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Grifols Therapeutics LLCCompletedA Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis ExacerbationsMyasthenia Gravis ExacerbationsBelgium, Poland, Canada, Argentina, Estonia, France, Hungary, Romania, Czechia, Latvia, Russian Federation, South Africa
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); AstraZeneca; University of... and other collaboratorsActive, not recruitingCOVID-19United States, Denmark, Greece, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaboratorsCompletedCOVID-19United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline; University... and other collaboratorsCompletedCOVID-19United States, Denmark, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
PfizerCompletedCOVID-19United States, Taiwan, Italy, Canada, Greece
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
Invivyd, Inc.TerminatedCOVID-19United States, Argentina, Czechia, Georgia, Germany, Moldova, Republic of, Poland, Romania, Ukraine
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences; University... and other collaboratorsCompleted
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
Eli Lilly and CompanyGlaxoSmithKline; Shanghai Junshi Bioscience Co., Ltd.; Vir Biotechnology, Inc.; AbCellera Biologics Inc...CompletedCOVID-19United States, Puerto Rico, Argentina
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
Daniel BenjaminNational Center for Advancing Translational Sciences (NCATS); Biomedical Advanced...CompletedCovid19United States, Brazil, Argentina, Mexico, Peru
-
National Institute of Allergy and Infectious Diseases...Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaboratorsCompletedCovid19United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
-
Cynata Therapeutics LimitedCerebral Palsy AllianceCompletedCovid19 | Acute Respiratory Distress SyndromeAustralia
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
BioNTech SEPfizerActive, not recruiting
-
ModernaTX, Inc.Active, not recruitingCOVID-19United States, United Kingdom, Canada
-
MediMergent, LLCTerminatedSARS-CoV-2 InfectionUnited States
-
Partner Therapeutics, Inc.United States Department of DefenseCompletedCovid19 | SARS-CoV InfectionUnited States, Argentina
-
QuantumLeap Healthcare CollaborativeM.D. Anderson Cancer Center; University of Colorado, Denver; University of Pennsylvania and other collaboratorsRecruitingCOVID-19United States
-
ASH Research CollaborativeUniversity of Pennsylvania; American Society of HematologyCompleted
-
University of MiamiNational Institute of Neurological Disorders and Stroke (NINDS); St. Jude Children... and other collaboratorsEnrolling by invitationAmyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Frontotemporal Dementia | Progressive Muscular Atrophy | Hereditary Spastic Paraplegia | Multisystem ProteinopathyUnited States, South Africa, Germany